OxyTrex is a new drug cuurently in Phase III trials and still pending approval. OxyTrex combines an ultra tiny dose of naltrexone with oxycodone. This eliminates most of the tolerance and dependance is reduced as well. studies with ultra low dose naltrexone and morphine showed morphine restored to 80% - 90% of original effectiveness.

WRITE to the FDA and DEA and BEG THEM with all your heart and might to let OxyTrex be Unscheduled